Bahar Laderian, MD, is an Assistant Professor of Medicine and Oncology at the Albert Einstein College of Medicineand the Director of the Neuroendocrine Tumors Program at the Montefiore Einstein Comprehensive Cancer Centerin New York. A clinician–scientist specializing in complex and rare malignancies, she provides advanced expertise in neuroendocrine tumors and carcinomas, pheochromocytomas, paragangliomas, and a broad spectrum of gastrointestinal cancers including colorectal, appendiceal, intestinal, anal, pancreatic, hepatocellular, cholangiocarcinoma, esophageal, and gastric cancers.
Dr. Laderian completed her medical degree at the University of Pittsburgh School of Medicine, followed by an internal medicine residency at the University of Miami–Jackson Memorial Hospital. She subsequently trained in hematology and medical oncology through a fellowship at Columbia University Medical Center–NewYork-Presbyterian Hospital, where she refined her expertise in rare endocrine and gastrointestinal malignancies.
Her research program focuses on developing innovative treatments for neuroendocrine neoplasms, pheochromocytomas, paragangliomas, and gastrointestinal cancers. She collaborates closely with basic scientists to identify genomic alterations that can guide therapy and predict severe treatment-related toxicities. Dr. Laderian’s research further explores disparities in clinical outcomes among patients with rare tumors, as well as the role of population genetics in influencing cancer risk, treatment responses, and overall health trajectories.
An active contributor to oncology scholarship, Dr. Laderian has authored and co-authored numerous peer-reviewed publications in leading cancer journals and has presented her research at national and international conferences. Her commitment to advancing the field has been recognized through several distinctions, including the ASCO Conquer Cancer Foundation Young Investigator Award (2019). From 2022 to 2024, she served as the youngest member of the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumor Panel, contributing to guideline development for these rare diseases.
Dr. Laderian is board certified in Internal Medicine and Medical Oncology. She serves on the Editorial Board of OncoDaily, reflecting her commitment to global oncology education, scientific communication, and multidisciplinary collaboration.
Office address:
Montefiore Medical Park
1695 Eastchester Road
Bronx, NY 10461, USA
Email: [email protected]
She is a Member of the Editorial Board of OncoDaily.